Harlan Grogin is a Cardiology physician. OpenAlex indexes 12 publications with 1,047 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
230 San Jose St
Salinas, CA 939013901
Telephone
831-758-2100Registry record last updated 7 Nov 2013.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year202516 payments
- Abbott LaboratoriesProgram year202552 payments
- Medtronic, Inc.Program year202576 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.4%Antiarrhythmic22.7%Propafenone Hcl38%Amiodarone Hcl33%Flecainide Acetate20%Dofetilide4%Multaq4%Part D<11 patientsBeta blocker18.8%Metoprolol Succinate36%Carvedilol27%Metoprolol Tartrate26%Sotalol12%Part D≥61 patients+ 16 more classes in this area
Blood & clotting
15.4%Factor Xa inhibitor10.3%Eliquis92%Xarelto9%Part D<11 patientsVitamin K antagonist2.8%Warfarin Sodium100%Part D≥28 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.1%SGLT2 inhibitor2.7%Jardiance84%Farxiga17%Part D<11 patientsProton pump inhibitor1.3%Pantoprazole Sodium100%Part D≥35 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 1008-15 Effectiveness of Heparin for Prevention of Coagulation Factor Activation During Radiofrequency Catheter Ablation
Journal of the American College of Cardiology
1995
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”